New York Health Care Announces a Necessary Change of Its New Ticker Symbol Effective Monday, April 7, 2003.Business Editors/Health/Medical Writers BROOKLYN, N.Y.--(BUSINESS WIRE)--April 4, 2003 New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of Health Care, Inc. (Nasdaq SmallCap: NYHC NYHC New York Hardcore ) today announced that effective Monday, April 7, 2003, its ticker symbol on the Nasdaq SmallCap Market will change from BIOB to "BBAL." Commenting on this pending change Jerry Braun, the company's CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. stated, "Earlier today, Nasdaq notified us that the symbol "BIOB" had been issued to us in error and was actually reserved by a company listed on the American Stock Exchange American Stock Exchange (AMEX) Stock exchange in the U.S. Originally known as “the Curb,” it began as an outdoor marketplace in New York City c. 1850. It moved indoors to its present location in the Wall Street area in 1921. . Nasdaq asked that we select a new symbol. Our first choice, "BBAL," has been accepted by Nasdaq and the company's securities will begin trading on Monday morning, April 7, under this new ticker symbol." "The company's securities are also listed and quoted on the Boston Stock Exchange The Boston Stock Exchange (BSE) is a regional stock exchange located in Boston, Massachusetts. The third-oldest stock exchange in the United States, it was founded in 1834. On October 2nd, 2007 Nasdaq agreed to acquire BSE for $61 million. , and we anticipate a change in the company's ticker symbol on that exchange in the next few days," added Mr. Braun. Commenting on the change, Paul Stark, President of The Bio Balance Corp. stated, "We realize that this may cause some temporary confusion, but we trust that our new ticker symbol will quickly be associated with our company and its message." Bio Balance owns "probiotic pro·bi·ot·ic n. A dietary supplement containing live bacteria or yeast that supplements normal gastrointestinal flora, given especially after depletion of flora caused by infection or ingestion of an antibiotic drug. " technology, intellectual property and has a fully developed product for the treatment of gastrointestinal diseases and disorders in animals and humans, including Irritable Bowel Syndrome irritable bowel syndrome (IBS), condition characterized by frequently alternating constipation and diarrhea in the absence of any disease process. It is usually accompanied by abdominal pain, especially in the lower left quadrant, bloating, and flatulence. ("IBS IBS Irritable bowel syndrome, see there ") and chronic diarrhea. It is in the process of compliance with applicable regulatory requirements for the introduction of its first product, PROBACTRIX(TM), to the United States market as a medical food. Depending on which published articles one consults, the number of Americans that suffer from Irritable Bowel Syndrome ("IBS") is approximately 40 million. Overall, it is estimated that there are over 100 million IBS sufferers around the world. New York Health Care is a licensed home health care agency engaged primarily in supplying the services of paraprofessionals who provide a broad range of health care support services to patients in their homes. SAFE HARBOR STATEMENT In addition to historical information, certain of the statements in the preceding paragraphs, particularly those anticipating future events, financial performance, business prospects and growth and operating strategies constitute forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Such statements may be identified by words such as anticipate, believe, estimate, expect, intend, predict, hope or similar expressions. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements, including, without limitation, satisfaction of approvals and conditions applicable to the transaction described above, the Company's ability to implement its strategies and achieve its objectives and the risks and uncertainties described in reports filed by NYHC with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, including without limitation, cautionary statements made in NYHC's 2002 Annual Report on Form 10-K and NYHC's Form S-4 Registration Statement. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion